HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shizuo Yamada Selected Research

Constipation

8/2019Effect of Royal Jelly on Mouse Isolated Ileum and Gastrointestinal Motility.
1/2018Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shizuo Yamada Research Topics

Disease

25Overactive Urinary Bladder (Overactive Bladder)
01/2024 - 11/2004
15Asthma (Bronchial Asthma)
01/2012 - 12/2004
13Chronic Obstructive Pulmonary Disease (COPD)
01/2012 - 05/2004
11Phototoxic Dermatitis (Phototoxicity)
12/2013 - 03/2008
9Inflammation (Inflammations)
04/2014 - 05/2004
7Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2022 - 07/2007
6Lower Urinary Tract Symptoms
05/2018 - 04/2009
5Body Weight (Weight, Body)
12/2019 - 12/2009
4Cystitis
01/2014 - 10/2010
3Fatigue
01/2020 - 01/2018
3Ischemia
04/2014 - 12/2002
3Achlorhydria (Hypochlorhydria)
01/2013 - 04/2012
3Type 2 Diabetes Mellitus (MODY)
01/2011 - 12/2004
3Lung Diseases (Lung Disease)
09/2007 - 12/2004
2Dementia (Dementias)
04/2023 - 01/2020
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2023 - 01/2020
2Mitochondrial Diseases (Mitochondrial Disease)
04/2023 - 02/2021
2Neuroinflammatory Diseases
04/2023 - 02/2021
2Atopic Dermatitis (Atopic Eczema)
01/2023 - 02/2010
2Constipation
08/2019 - 01/2018
2Infarction (Infarctions)
04/2014 - 02/2007
2Brain Ischemia (Cerebral Ischemia)
04/2014 - 12/2002
2Atherosclerosis
01/2014 - 07/2012
2Pneumonia (Pneumonitis)
06/2013 - 01/2010
2Idiopathic Pulmonary Fibrosis
06/2013 - 03/2013
2Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2013 - 06/2012
2Pain (Aches)
02/2013 - 01/2011
2Prostatic Neoplasms (Prostate Cancer)
01/2013 - 10/2011
2Insulinoma
01/2011 - 11/2008
2Mental Disorders (Mental Disorder)
01/2010 - 08/2005
2Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
02/2009 - 02/2007
1Major Depressive Disorder (Major Depressive Disorders)
04/2023
1Schizophrenia (Dementia Praecox)
04/2023
1Skin Diseases (Skin Disease)
01/2023
1Alzheimer Disease (Alzheimer's Disease)
12/2021
1Hypersensitivity (Allergy)
05/2021

Drug/Important Bio-Agent (IBA)

24Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2024 - 11/2004
11Muscarinic AntagonistsIBA
01/2024 - 01/2006
8oxybutynin (Tavor)FDA LinkGeneric
09/2012 - 11/2004
6saw palmetto extractIBA
03/2022 - 03/2009
6AntigensIBA
05/2021 - 01/2011
6Cholinergic Agents (Cholinergics)IBA
01/2014 - 05/2008
6Neutral RedIBA
12/2013 - 03/2008
6Reactive Oxygen Species (Oxygen Radicals)IBA
12/2013 - 08/2008
6PowdersIBA
06/2013 - 06/2009
5Cholinergic Antagonists (Anticholinergics)IBA
01/2019 - 07/2006
5imidafenacinIBA
01/2017 - 02/2011
5Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
06/2012 - 09/2007
5Arg(15,20,21)-Leu(17)- vasoactive intestinal peptide-GRRIBA
11/2010 - 12/2004
4CytokinesIBA
01/2023 - 01/2013
4Solifenacin SuccinateFDA Link
01/2016 - 08/2009
4Purinergic Receptors (Receptors, Purine)IBA
01/2014 - 05/2008
4Therapeutic UsesIBA
01/2014 - 07/2007
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2014 - 05/2008
4Biomarkers (Surrogate Marker)IBA
06/2013 - 06/2009
4DNA (Deoxyribonucleic Acid)IBA
03/2013 - 10/2008
4Tolterodine Tartrate (Detrol)FDA Link
09/2012 - 01/2006
4tranilastIBA
06/2012 - 02/2010
3MetalsIBA
04/2023 - 01/2020
3nobiletinIBA
12/2021 - 09/2011
3Dipyridamole (Persantine)FDA LinkGeneric
01/2013 - 04/2012
2Amyloid (Amyloid Fibrils)IBA
04/2023 - 09/2011
2Adrenergic Receptors (Adrenergic Receptor)IBA
12/2021 - 08/2011
2EnzymesIBA
01/2021 - 09/2013
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2019 - 01/2010
2TeaIBA
01/2015 - 01/2013
2Neuroprotective AgentsIBA
04/2014 - 12/2002
2flavoneIBA
04/2014 - 09/2011
2pirfenidoneIBA
06/2013 - 03/2013
2eviprostatIBA
03/2013 - 07/2012
2SolutionsIBA
02/2013 - 01/2011
2AndrogensIBA
01/2013 - 10/2011
2Omeprazole (Prilosec)FDA LinkGeneric
01/2013 - 04/2012
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2012 - 08/2009
2O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
09/2011 - 09/2010
2Drug Receptors (Drug Receptor)IBA
08/2011 - 01/2010
2darifenacinFDA Link
08/2011 - 02/2007
2silodosinFDA Link
08/2011 - 07/2007
2propiverineIBA
08/2011 - 06/2007
2Tamsulosin (Flomax)FDA LinkGeneric
08/2011 - 07/2007
2Anti-Allergic Agents (Antiallergic Agents)IBA
02/2011 - 02/2010
2Peptides (Polypeptides)IBA
01/2011 - 12/2004
2Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
01/2011 - 12/2004
2SmokeIBA
11/2010 - 12/2004
2OvalbuminIBA
01/2010 - 06/2009
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2010 - 08/2005
2Protease Inhibitors (Protease Inhibitor)IBA
08/2009 - 05/2004
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2009 - 11/2008
21,4-dihydropyridine (dihydropyridine)IBA
04/2009 - 03/2008
2Fatty Acids (Saturated Fatty Acids)IBA
10/2008 - 03/2008
1SynucleinsIBA
04/2023
1AllergensIBA
01/2023
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2023
1N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA
12/2021
1Muramidase (Lysozyme)IBA
05/2021

Therapy/Procedure

10Therapeutics
01/2021 - 12/2004
7Oral Administration
05/2021 - 02/2007
3Dry Powder Inhalers
01/2011 - 08/2009
2Drug Therapy (Chemotherapy)
12/2021 - 08/2009
2Respiratory Therapy (Therapy, Respiratory)
01/2010 - 08/2009